B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Richard A Furie; Gustavo Aroca; Matthew D Cascino; Jay P Garg; Brad H Rovin; Analia Alvarez; Hilda Fragoso-Loyo; Elizabeth Zuta-Santillan; Thomas Schindler; Paul Brunetta

doi:10.1136/annrheumdis-2021-220920

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Identifier:nobleid.org/w1/20260526/C1FADC27

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1FADC27.svg?ark=w1%2F20260526%2FC1FADC27)](https://nobleid.org/work/w1/20260526/C1FADC27)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Elizabeth Zuta-Santillan

Thomas Schindler

Paul Brunetta

Claim authorship of this work

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Identifier:nobleid.org/w1/20260526/C1FADC27

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C1FADC27.svg?ark=w1%2F20260526%2FC1FADC27)](https://nobleid.org/work/w1/20260526/C1FADC27)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Elizabeth Zuta-Santillan

Thomas Schindler

Paul Brunetta

Claim authorship of this work